Charming Medical Limited Class A Ordinary Shares
Charming Medical Limited Class A Ordinary Shares (MCTA) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
mcta · pe ratio · data through Mar 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Charming Medical Limited Class A Ordinary Shares (MCTA) measures how much investors pay for each dollar of the company's trailing earnings. MCTA's current PE ratio of 414.66x is calculated by dividing its stock price of $29.36 by its TTM earnings per share of $0.07. +230.0% elevated vs 5Y avg 125.7x
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-03-31
PE Ratio History
2023 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Care Facilities · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Charming Medical Limited Class A Ordinary SharesYou MCTA | $446M | 414.66x | — | $0.07 |
 Agilon Health, Inc. AGL | $1.6B | N/A | — | -$24.48 |
 Annexon, Inc. ANNX | $612M | N/A | — | -$1.33 |
 Cross Country Healthcare, Inc. CCRN | $426M | N/A | — | -$2.93 |
 Delcath Systems, Inc. DCTH | $378M | 134.00x | — | $0.08 |
 Enhabit, Inc. EHAB | $707M | N/A | — | -$0.09 |
 Nakamoto Inc. NAKA | $4.5B | N/A | — | -$4.60 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-03-31Latest FY2025 | 98.88x | $0.07 | -35.1% | |
2024-03-31 FY2024 | 152.44x | $0.05 | — | |
2023-03-31 FY2023 | — | $-0.02 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Charming Medical Limited Class A Ordinary Shares (MCTA) measures how much investors pay for each dollar of the company's trailing earnings. MCTA's current PE ratio of 414.66x is calculated by dividing its stock price of $29.36 by its TTM earnings per share of $0.07.
Frequently asked questions
MCTA pe ratio · 6 questionsMCTA's current PE ratio is 414.66x as of 2026-06-08, based on a stock price of $29.36 and TTM EPS of $0.07. Data sourced from Financial Modeling Prep via MCTA's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Charming Medical Limited Class A Ordinary Shares SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08